Blue Trust’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Blue Trust's BBIO Position: Q3 2026 in Review
Blue Trust reduced its BridgeBio Pharma (BBIO) stake by 88% in Q3 2026, selling an estimated $10.7K and leaving 18 shares worth $1.18K. The position accounts for ﹤0.01% of the portfolio, ranked #2146.
Blue Trust first reported a position in BBIO in Q4 2023 and has held it in 8 quarters since. The position peaked at $12.4K in Q1 2025. 359 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.
- Blue Trust held 18 shares of BridgeBio Pharma worth $1.18K as of Q3 2026.
- Blue Trust sold 137 BridgeBio Pharma shares in Q3 2026, an estimated $10.7K.
- BridgeBio Pharma made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2146 holding.
- Blue Trust first reported a position in BridgeBio Pharma in Q4 2023 and has held it in 8 quarters since.
- Blue Trust's BridgeBio Pharma position peaked at $12.4K in Q1 2025.
- 359 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.